BUND FINANCE

BUND FINANCE › Stocks › MRK

Merck & Co., Inc. (MRK)

NYSE · Stock price, chart and technical analysis

US$137.78-5.59 (-3.90%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:02 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$143.37
OpenUS$141.09
Day rangeUS$136.79 – US$142.34
52-week rangeUS$93.90 – US$156.92
Market capUS$339.66B
Volume9.69M
50-day averageUS$145.91
200-day averageUS$128.97
Beta0.22
Last dividend per shareUS$3.40

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$48.7BUS$59.3BUS$60.1BUS$64.2BUS$64.9B
Net incomeUS$13.0BUS$14.5BUS$365.0MUS$17.1BUS$18.3B
EPS (diluted)5.145.710.146.747.28
Gross margin72.0%70.6%73.2%76.3%72.0%
Operating margin27.1%30.8%4.9%31.5%36.2%
Net margin26.8%24.5%0.6%26.7%28.1%
Free cash flowUS$9.7BUS$14.7BUS$9.1BUS$18.1BUS$12.4B
Total debtUS$34.6BUS$32.0BUS$36.3BUS$38.3BUS$50.5B
CashUS$8.1BUS$12.7BUS$6.8BUS$13.2BUS$14.6B

Compound annual growth: revenue 7.5% · net income 8.8% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E142.0x168.4x27.1x
EV / EBITDA32.5x18.4x16.5x
Operating margin13.6%—3.6%
Net margin3.6%—-0.0%
Debt / equity1.96—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About Merck & Co., Inc.

SectorHealthcare
IndustryDrug Manufacturers - General
CountryUS
CEORobert Davis
Employees74,000
IPO date1978-01-13

Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This div…

www.merck.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice